From: “Life-changing”: the experience of super-responders to biologics in severe asthma
Pre biologic | Post biologic | |
---|---|---|
n (%) | ||
Participants requiring maintenance OCS | 12 (48) | 5 (20) |
Mean (range) | ||
Maintenance OCS dose (mg/d) | 12.5 (5–30) | 5 (0–10) |
Exacerbations requiring OCS in last 12 months | 8 (4–16) | 0.3 (0–1) |
Mean (SD) | ||
FEV1-Absolute (L) | 2.37 (0.70) | 2.47 (0.77) |
% Predicted | 79.4 (18.80) | 81.2(25.15) |
ACQ 6 (0–6) | 2.60 (1.15) | 0.81 (0.83) |
SAQ (0–7) | 3.81 (1.26) | 6.01 (0.91) |
SAQ Global (0–100) | 53 (21.38) | 88 (12.59) |